(NASDAQ: PHIO) Phio Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.56%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.28%.
Phio Pharmaceuticals's earnings in 2025 is -$7,085,000.On average, 1 Wall Street analyst forecast PHIO's earnings for 2025 to be -$10,308,150, with the lowest PHIO earnings forecast at -$10,308,150, and the highest PHIO earnings forecast at -$10,308,150. On average, 1 Wall Street analyst forecast PHIO's earnings for 2026 to be -$5,383,145, with the lowest PHIO earnings forecast at -$5,383,145, and the highest PHIO earnings forecast at -$5,383,145.
In 2027, PHIO is forecast to generate -$2,634,305 in earnings, with the lowest earnings forecast at -$2,634,305 and the highest earnings forecast at -$2,634,305.